Palisade Bio Inc
Insider Buying at Palisade Bio Signals Confidence Amid Volatility
Insider buying at Palisade Bio signals confidence amid volatility, yet investors should weigh the company’s GI‑therapeutic potential against its high‑risk profile.
4 minutes to read
Paladate Bio Insider Buy Signals Confidence Ahead of Crohn’s NDA Filing
Palaisade Bio insider buy signals confidence in its Phase III Crohn’s drug; watch for FDA filing and market launch in 2026.
4 minutes to read


